EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes

Takatoshi Sakata, Kazuo Kunisawa, Masaya Hasegawa iD, Yumiko Seto, Aoi Ogawa, Hitomi Kurahashi, Yasuko Yamamoto, Masao Takemura, Hidetoshi Matunami, Tomoya Sugai, Noriki Kutsumura, Kuniaki Saito and 2 more

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70288 ↗

At a glance

Journal article in British Journal of Pharmacology, 2025. Written by Takatoshi Sakata and 13 co-authors. Institution: Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Medical …. Major MEDLINE topics: Norepinephrine, Major Depressive Disorder, Sucrose, Antidepressive Agents. 86 references. The full text is freely available (open access, CC BY 4.0). Funded by: Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan Science and Technology Agency (JST) FOREST Program, SPRING Program.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background and Purpose Lifestyle is closely related to major depressive disorder (MDD). Given the growing focus on the impact of diet on mental health, this study examined how dietary habits affect the pathophysiology of MDD. Experimental Approach Health check‐up data were analysed. Mice received sucrose under chronic unpredictable mild stress (CUMS) and were evaluated by behavioural, neurochemical and metabolic analysis. Key Results Health check‐up data showed increased sucrose intake in MDD patients. When mice received sucrose under CUMS, hyperactivity and aggression were attenuated, although social deficits or behavioural despair induced by CUMS persisted, and recognition memory was impaired. The behavioural changes were associated with dysfunction of the locus coeruleus‐prefrontal cortex circuit, caused by impaired noradrenaline release due to presynaptic α 2 ‐adrenoceptor upregulation, and postsynaptic α 1 ‐adrenoceptor and β 1 ‐adrenoceptor downregulation. α 2 ‐Adrenoceptor antagonism by atipamezole rescued behavioural changes induced by sucrose intake under CUMS, whereas α 2 ‐adrenoceptor agonism by guanfacine in CUMS mice mimicked these behavioural changes. Among the antidepressants, mirtazapine effectively increased noradrenaline release and rescued behavioural changes induced by sucrose intake under CUMS. Sucrose intake under CUMS induced peripheral hyperglycaemia and dysregulation of central glucose metabolism. Glucose transporter inhibition by phloretin rescued behavioural changes induced by sucrose intake under CUMS. Intracerebroventricular and systemic streptozotocin administration reproduced these behavioural changes and α 2 ‐adrenoceptor upregulation. Conclusions and Implications Our findings suggest that the observed behavioural changes are associated with dysfunction of the noradrenergic α 2 ‐adrenoceptor system induced by impaired glucose metabolism. These insights targeting the noradrenergic‐metabolic axis might be a new strategy for sugar‐induced depression subtypes.

Subjects

MeSH terms (MEDLINE)

NorepinephrineMajor Depressive DisorderSucroseAntidepressive AgentsAnimalsMaleMiceHumansMice, Inbred C57BLAdultStress, PsychologicalMiddle AgedBehavior, AnimalFemale

Author keywords

adrenoceptordiabetesmajor depressive disordermousenoradrenalinesucrose

Substances

NorepinephrineSucroseAntidepressive Agents

Authors and institutions

  • Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Medical Sciences, Toyoake, Japan.
  • International Center for Brain Science (ICBS), Fujita Health University, Toyoake, Japan.
  • Japanese Drug Organization of Appropriate Use and Research, Nagoya, Japan.
  • Advanced Diagnostic System Development, Fujita Health University, Graduate School of Medical Sciences, Toyoake, Japan.
  • Matsunami Research Park, Gifu, Japan.
  • Matsunami General Hospital, Gifu, Japan.

ORCID profiles: Masaya Hasegawa, Akihiro Mouri

Funding

  • Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science
  • Japan Science and Technology Agency (JST) FOREST Program
  • SPRING Program
  • Education and Research Facility of Animal Models for Human Diseases at Fujita Health University
  • Smoking Research Foundation
  • Takeda Science Foundation

Cite

APA

Sakata, T., Kunisawa, K., Hasegawa, M., Seto, Y., Ogawa, A., Kurahashi, H., Yamamoto, Y., Takemura, M., Matunami, H., Sugai, T., Kutsumura, N., Saito, K., Nabeshima, T., & Mouri, A. (2025). Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes. British Journal of Pharmacology. https://doi.org/10.1111/bph.70288

Vancouver

Sakata T, Kunisawa K, Hasegawa M, Seto Y, Ogawa A, Kurahashi H, et al. Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes. British Journal of Pharmacology. 2025. doi:10.1111/bph.70288

BibTeX
@article{Sakata2025,
  author = {Sakata, Takatoshi and Kunisawa, Kazuo and Hasegawa, Masaya and Seto, Yumiko and Ogawa, Aoi and Kurahashi, Hitomi and Yamamoto, Yasuko and Takemura, Masao and Matunami, Hidetoshi and Sugai, Tomoya and Kutsumura, Noriki and Saito, Kuniaki and Nabeshima, Toshitaka and Mouri, Akihiro},
  title = {Targeting the noradrenergic‐metabolic axis: A new strategy for sugar‐induced depression subtypes},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70288}
}
Start for free →